Somaxon Provides Update On New Drug Application For Silenor(R) (doxepin) For The Treatment Of Insomnia

Somaxon Provides Update On New Drug Application For Silenor(R) (doxepin) For The Treatment Of Insomnia
Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded pharmaceutical products for the treatment of diseases and disorders in the central nervous system therapeutic area, today provided an update on the status of its New Drug Application (NDA) for Silenor® (doxepin) for the treatment of insomnia. Somaxon held a meeting with the Division of Neurology Products of the U.

Cognitive Behavior Therapy Eases Anxiety for Older People
Title: Cognitive Behavior Therapy Eases Anxiety for Older People
Category: Health News
Created: 4/8/2009 2:00:00 AM
Last Editorial Review: 4/8/2009

Baby's Sleep Position May Not Affect Severity of Head Flattening
Title: Baby's Sleep Position May Not Affect Severity of Head Flattening
Category: Health News
Created: 3/28/2009 2:00:00 AM
Last Editorial Review: 3/30/2009

Missing Or Mutated "Clock" Gene Linked To Vascular Disease
The circadian clocks that set the rhythmic motion of our bodies for wakeful days and sleepy nights can also set us up for vascular disease when broken, Medical College of Georgia researchers say. Mice with mutated or missing "clock" genes are prone to thick, inflexible blood vessels with narrow passageways, unhealthy changes typically associated with risk factors such as smoking, high blood pressure and cholesterol, according to research in this week's issue of Circulation.

What's in a Dream?

Study Challenges Link Between Panic Attacks, PTSD
Title: Study Challenges Link Between Panic Attacks, PTSD
Category: Health News
Created: 4/11/2009 2:00:00 AM
Last Editorial Review: 4/13/2009